Patents-Review.com
ClassID:

21426 ⎘

A61K49/003 - CPC Classification

Classification description:

Preparations for testing; Preparation for luminescence or biological staining; Luminescence; Fluorescence characterised by the fluorescent group the fluorescent group being a small organic molecule Thiazine dyes

Recent Application in this class:
#1
20250186626
2025-06-12

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

 #2
20250018066
2025-01-16

Ophthalmic dye composition

 #3
20230226226
2023-07-20

Multi-signal fluorescent probe for early diagnosis of tumors, and preparation and use thereof

 #4
20230130628
2023-04-27

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

 #5
20220387631
2022-12-08

NEAR-INFRARED FLUORESCENT CONTRAST BIOIMAGING AGENTS AND METHODS OF USE THEREOF

 #6
20220273823
2022-09-01

THERANOSTIC CONJUGATES

 #7
20220257804
2022-08-18

FILM-FORMING AGENT COMPOSITION FOR CONTRAST AGENT, FILM-FORMING LIPID SOLUTION FOR CONTRAST AGENT, CONTRAST AGENT AND PREPARATION METHOD THEREOF

 #8
20220241437
2022-08-04

ATHEROSCLEROSIS IMAGING AGENTS AND METHODS OF USING THE SAME

 #9
20210213144
2021-07-15

OPHTHALMIC DYE COMPOSITION

 #10
20200268909
2020-08-27

SOLID COMPOSITION FOR THE ORAL ADMINISTRATION OF DYES AND DIAGNOSTIC USE THEREOF

 #11
20200129643
2020-04-30

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

 #12
20190358348
2019-11-28

CHARACTERIZATION OF BIOLOGICAL TISSUES AT A CELLULAR LEVEL USING RED AND FAR-RED FLUORESCENT DYES

 #13
20190338340
2019-11-07

5,5-disubstituted luciferins and their use in luciferase-based assays

 #14
20190000974
2019-01-03

Method for treating cancer by photodynamic therapy

 #15
20180214580
2018-08-02

SOLID COMPOSITION FOR THE ORAL ADMINISTRATION OF DYES AND DIAGNOSTIC USE THEREOF

 #16
20180055953
2018-03-01

ATHEROSCLEROSIS IMAGING AGENTS AND METHODS OF USING THE SAME

 #17
20170368202
2017-12-28

Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo

 #18
20170258939
2017-09-14

Staining composition

 #19
20170216461
2017-08-03

Composite Nanodots Based on Carbon Nanodots and Preparation Method Thereof

 #20
20170119907
2017-05-04

Targeted Therapeutics

 #21
20170106102
2017-04-20

Nanoparticles for diagnosis and treatment of tumors

 #22
20160347727
2016-12-01

Near-infrared fluorescent nerve contrast agents and methods of use thereof

 #23
20160339123
2016-11-24

POLYBUTYLACRYLATE-BASED NANOCOMPOSITE PHOTOACOUSTIC IMAGING AGENT AND A PREPARATION METHOD THEREOF

 #24
20160310010
2016-10-27

Method of imaging living tissue

 #25
20160263249
2016-09-15

Near-infrared fluorescent contrast bioimaging agents and methods of use thereof

 #26
20160193365
2016-07-07

Near-infrared fluorescent surgical dye markers

 #27
20160184460
2016-06-30

Solid composition for the oral administration of dyes and diagnostic use thereof

 #28
20150273084
2015-10-01

Methylene blue nanoparticle for bioimaging and photodynamic therapy and use thereof

 #29
20150104394
2015-04-16

CHARACTERIZATION OF BIOLOGICAL TISSUES AT A CELLULAR LEVEL USING RED AND FAR-RED FLUORESCENT DYES

 #30
20140221665
2014-08-07

Luminescent substrate for luciferase

 #31
20140058072
2014-02-27

Multimeric peptidomimetic fibrosis specific dual-modality probes

 #32
20130295013
2013-11-07

Solid composition for the oral administration of dyes and diagnostic use thereof

 #33
20130287690
2013-10-31

Solid composition for the oral administration of dyes and diagnostic use thereof

 #34
20130259805
2013-10-03

Development and screening of contrast agents for in vivo imaging of Parkinson's disease

 #35
20130149251
2013-06-13

Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo

 #36
20130058867
2013-03-07

Solid composition for the oral administration of dyes and diagnostic use thereof

 #37
20130052138
2013-02-28

Methods and compositions for diagnostic and therapeutic targeting of COX-2

 #38
20130045167
2013-02-21

Staining composition

 #39
20120302557
2012-11-29

BIOLOGICALLY ACTIVE METHYLENE BLUE DERIVATIVES

 #40
20110118242
2011-05-19

3,7-diamino-10H-phenothiazine salts and their use

 #41
20110117024
2011-05-19

Nanocarrier and nanogel compositions

 #42
20100273205
2010-10-28

Magnetic resonance imaging contrast agents

 #43
20100254910
2010-10-07

Methods and compositions for diagnostic and therapeutic targeting of COX-2

 #44
20100098637
2010-04-22

DYE-LOADED NANOPARTICLE

 #45
20090209526
2009-08-20

Inhibitors of protein aggregation

 #46
20090092552
2009-04-09

Light stabilized in vivo stain composition and method of manufacture

 #47
20080312219
2008-12-18

Biologically active methylene blue derivatives

 #48
20080275033
2008-11-06

Biologically active methylene blue derivatives

 #49
20080268033
2008-10-30

Biologically active methylene blue derivatives

 #50
20080261960
2008-10-23

Biologically active methylene blue derivatives

 #51
20070292352
2007-12-20

Methods and compositions for diagnostic and therapeutic targeting of COX-2

 #52
20070081945
2007-04-12

Magnetic resonance imaging contrast agents